Area of research
Radiology, Nuclear Medicine and Imaging · Surgery
Research interest
Research focused on Cardiology and Myocardial infarction, with related work in Coronary artery disease, Hazard ratio, Mace. Notable publications include 'Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease', 'Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia', and 'Safety of Coronary Reactivity Testing in Women With No Obstructive Coronary Artery Disease'.
Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation
Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women
Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD)
Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease
Ten-Year Mortality in the WISE Study (Women’s Ischemia Syndrome Evaluation)
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE)
Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study
Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome
Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE)
Cardiovascular and Mortality Risk of Apparent Resistant Hypertension in Women With Suspected Myocardial Ischemia: A Report From the NHLBI‐Sponsored WISE Study
Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease
Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: Findings from the National Heart, Lung, and Blood Institute–sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory
Safety of Coronary Reactivity Testing in Women With No Obstructive Coronary Artery Disease
Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial